Boston Scientific Files 8-K on Financials

Ticker: BSX · Form: 8-K · Filed: Apr 24, 2024 · CIK: 885725

Boston Scientific CORP 8-K Filing Summary
FieldDetail
CompanyBoston Scientific CORP (BSX)
Form Type8-K
Filed DateApr 24, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: financial-results, 8-k

Related Tickers: BSX

TL;DR

BSX filed an 8-K on 4/24 detailing financial results.

AI Summary

Boston Scientific Corporation filed an 8-K on April 24, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance.

Why It Matters

This filing provides investors with crucial updates on Boston Scientific's financial health and operational performance, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Boston Scientific Corporation's results of operations and financial condition, including financial statements and exhibits.

When was this 8-K filing submitted?

This 8-K filing was submitted on April 24, 2024.

What is Boston Scientific Corporation's state of incorporation?

Boston Scientific Corporation is incorporated in Delaware.

What is Boston Scientific Corporation's IRS Employer Identification Number?

Boston Scientific Corporation's IRS Employer Identification Number is 04-2695240.

Where is Boston Scientific Corporation's principal executive office located?

Boston Scientific Corporation's principal executive office is located at 300 Boston Scientific Way, Marlborough, Massachusetts.

Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-04-24 06:34:09

Key Financial Figures

Filing Documents

02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On April 24, 2024, Boston Scientific Corporation issued a press release announcing financial results for the first quarter ended March 31, 2024. A copy of the release is furnished with this report as Exhibit 99.1. The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Boston Scientific Corporation dated April 24, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 24, 2024 BOSTON SCIENTIFIC CORPORATION By: /s/ Susan Thompson Susan Thompson Vice President, Chief Corporate Counsel and Assistant Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing